Dysregulated CCR5 signaling can precipitate maladaptive immune responses, thereby contributing to the pathogenesis of autoimmune disorders, such as rheumatoid arthritis (RA), multiple sclerosis (MS), and systemic lupus erythematosus (SLE). Here, CCR5 is linked to rheumatoid arthritis.